Pro 2014-026 (Jianfeng Group's First Extraordinary Shareholders' Meeting in 2014)-2
Release time:
2020-08-05
Annex 2: Online Voting Operation Process
Operation Process for Investors to Participate in Online Voting
At this shareholders' meeting, shareholders can vote through the online voting system provided by the SSE trading system during trading hours.
Voting date: trading hours on November 12, 2014, that is, 9:30-11:30 and 13:00-15:00. The online voting of the general meeting of shareholders through the SSE trading system is compared to the purchase of new shares on the SSE.
Total number of proposals: 12 (Note: If there is a proposal group, the group number is not included in the number of proposals, only the number of sub-proposals is counted. For example, there are a total of 3 proposals from 2.01 to 2.03 under the 2.00 of the proposal group. 2.00 this is a simplified way of voting on this group together, the 2.00 is not included in the number of proposals. in addition, the 99.00 of all proposals voted together is not included in the number of proposals)
1, voting process
(1) voting code
voting code |
voting for short |
number of events |
Voting Shareholder |
738668 |
Peak Voting |
12 |
A Share Shareholder |
(II) voting method
1, one-time voting method:
If a one-time vote is required on all matters, declare it as follows:
Proposal Serial Number |
Content |
Declaration Price |
Agree |
Oppose |
Abstain |
1-12 |
All 12 Proposals |
99.00 Yuan |
1 Shares |
2 Shares |
3 shares |
2, itemized voting method:
Proposal Serial Number |
Proposal Content |
Entrusted Price |
1.00 |
Proposal on Full Board of Directors |
1.00 |
1.01 |
elected Jiang Xiaomeng as the 9th board director |
1.01 |
1.02 |
elected Du Zihong as the 9th board director director of the board of directors |
1.02 |
1.03 |
elected Yu Jianhong as director of the ninth board of directors |
1.03 |
1.04 # |
elected Huang Sujian as director of the 9th board of directors |
1.04 |
1.05 |
elected Wu Guanghui as director of the 9th board of directors |
1.05 |
.06 |
elected Zhu Linming as director of the 9th board of directors |
1.06 |
1.07 |
elected Zhang Yuyou as independent director of the 9th board of directors |
1. 07 |
1.08 |
Election History Ximin as Independent Director of the 9th Board of Directors |
1.08 |
1.09 |
Election Wu Xiaoming as Independent Director of the 9th Board of Directors |
1.09 |
2.00 |
Proposal |
2.00 |
| # for the eighth board of supervisors supervisor |
2.01 |
|
| 2.02 |
election Ouyang Shaojian as the eighth board of supervisors supervisor |
2.02 |
| 2.03 # |
Elects Yuan Jie as Supervisor of the 8th Board of Supervisors |
2.03 |
| Voting Opinion Type |
Number of Declared Shares |
| Agree |
1 Unit |
| Oppose |
2 Unit |
| Abstention |
3 Unit |
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page